Cervical cancer is the fourth most common cancer in women. It is the leading cause of
female deaths in developing countries. Most of these cervical neoplasms are represented by …

Cervical cancer is the first identified human papillomavirus (HPV) associated cancer and the
most promising malignancy to be eliminated. However, the ever-changing virus subtypes …

Background Effective treatment is needed for advanced, inoperable, or chemotherapy-
resistant cervical cancer patients. Immunotherapy has become a new treatment modality for …

Cervical cancer is one of the most common and dangerous diseases for women. Initial
diagnosis and classification of cervical cancer are to reduce the mortality rate. The Pap …

Background Implementation of high-risk human papillomavirus (hrHPV) screening has
greatly reduced the incidence and mortality of cervical cancer. However, a triage strategy …

In early 1930, RE Shope paved the way for the recognition of human papillomavirus (HPV)
as a causative agent of some types of cancers. In early 2000, the relationship between HPV …

Cervical cancer (CC) is the fourth most frequent cancer in women worldwide. HPV infection
is associated with the majority of CC cases, but a small proportion of CCs actually test …

The introduction of genomic studies has enabled assessment of the clonality of synchronous
tumours involving the ovary and other sites in the female genital tract in a definitive way. This …

Simple Summary Although cervical cancer is mainly caused by infection with human
papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative …

Background The widespread introduction of Pap testing in the 1960s was followed by
substantial reductions in the incidence of cervical squamous cell cancer (SCC). However …